Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancers 14.13 (2022): 3282.
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2022
- Creator
-
Tomsitz, Dirk
Schlaak, Max
Zierold, Sarah
Pesch, Giulia
Schulz, Thomas U.
Müller, Genoveva
Zecha, Christine
French, Lars E.
Heinzerling, Lucie
- DOI
-
10.3390/cancers14133282
- URN
-
urn:nbn:de:bvb:29-opus4-199550
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:47 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tomsitz, Dirk
- Schlaak, Max
- Zierold, Sarah
- Pesch, Giulia
- Schulz, Thomas U.
- Müller, Genoveva
- Zecha, Christine
- French, Lars E.
- Heinzerling, Lucie
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2022
Other Objects (12)
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Determinants of survival in patients with brain metastases from cutaneous melanoma
Functional immunological parameters associated with long-term survival of patients with metastatic melanoma
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapy
Dynamic optical coherence tomography of blood vessels in cutaneous melanoma — correlation with histology, immunohistochemistry and dermoscopy
Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Determinants of survival in patients with brain metastases from cutaneous melanoma
Functional immunological parameters associated with long-term survival of patients with metastatic melanoma
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapy
Dynamic optical coherence tomography of blood vessels in cutaneous melanoma — correlation with histology, immunohistochemistry and dermoscopy
Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Determinants of survival in patients with brain metastases from cutaneous melanoma
Functional immunological parameters associated with long-term survival of patients with metastatic melanoma
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapy
Dynamic optical coherence tomography of blood vessels in cutaneous melanoma — correlation with histology, immunohistochemistry and dermoscopy